Short Interest in Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Decreases By 54.2%

Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) was the recipient of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 1,100 shares, a decrease of 54.2% from the August 15th total of 2,400 shares. Based on an average daily trading volume, of 1,500 shares, the short-interest ratio is presently 0.7 days.

Separately, Zacks Investment Research lowered shares of Ortho Regenerative Technologies from a “buy” rating to a “hold” rating in a report on Friday, August 27th.

Shares of OTCMKTS:ORTIF remained flat at $$0.38 during trading on Friday. Ortho Regenerative Technologies has a fifty-two week low of $0.00 and a fifty-two week high of $0.81. The stock has a 50-day moving average of $0.32 and a 200 day moving average of $0.38.

Ortho Regenerative Technologies (OTCMKTS:ORTIF) last announced its quarterly earnings data on Tuesday, June 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. Equities research analysts predict that Ortho Regenerative Technologies will post -0.11 EPS for the current fiscal year.

About Ortho Regenerative Technologies

Ortho Regenerative Technologies, Inc is a clinical stage orthobiologics company, which engages in the development of novel therapeutic soft tissue repair technologies for sports medicine surgeries. Its product pipeline include Rotator Cuff Repair, Meniscal Repair, and R&D Portfolio. The company was founded on February 5, 2015 and is headquartered in Kirkland, Canada.

Further Reading: Trading Strategy

Receive News & Ratings for Ortho Regenerative Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Regenerative Technologies and related companies with MarketBeat.com's FREE daily email newsletter.